Efficacy of personal protective equipment against coronavirus transmission via dental handpieces.

Severe acute respiratory syndrome-coronavirus 2 aerosols communicable disease control dental equipment face shields high-volume evacuation masks personal protective equipment respirators

Journal

Journal of the American Dental Association (1939)
ISSN: 1943-4723
Titre abrégé: J Am Dent Assoc
Pays: England
ID NLM: 7503060

Informations de publication

Date de publication:
08 2021
Historique:
received: 10 01 2021
revised: 28 02 2021
accepted: 15 03 2021
entrez: 30 7 2021
pubmed: 31 7 2021
medline: 4 8 2021
Statut: ppublish

Résumé

This laboratory study was done to evaluate the efficacy of personal protective equipment (PPE) and high-volume evacuation (HVE) against the spread of human coronavirus type 229E (HCoV-229E) during a standard dental procedure. Patient and operator manikins were used to recreate a dental setting inside a custom-built class III cabinet-like chamber. The mouth of the patient manikin was inoculated with an HCoV-229E suspension, the viral load of which was similar to that of asymptomatic people infected with severe acute respiratory syndrome coronavirus 2. The dental procedure was performed with an air turbine handpiece and HVE for 10 seconds. The efficacy of surgical masks, N95 (filtering facepiece class 2) and filtering facepiece class 3 respirators, and face shields was tested via quantitative real-time polymerase chain reaction. The wide surface on which the inoculum was spread caused low contamination. Over the external surfaces of masks and respirators, when a face shield was not worn, viral loads ranged from 1.2 through 1.4 log All PPE combinations significantly reduced viral loads in the operator manikin's mouth to below the detection limit, but HVE did not decrease viral contamination. Although caution is suggested when removing and disposing of PPE to avoid self-contamination, the combination of PPE and face shields drastically decreases the risk of transmitting human coronavirus during aerosol-generating dental procedures.

Sections du résumé

BACKGROUND
This laboratory study was done to evaluate the efficacy of personal protective equipment (PPE) and high-volume evacuation (HVE) against the spread of human coronavirus type 229E (HCoV-229E) during a standard dental procedure.
METHODS
Patient and operator manikins were used to recreate a dental setting inside a custom-built class III cabinet-like chamber. The mouth of the patient manikin was inoculated with an HCoV-229E suspension, the viral load of which was similar to that of asymptomatic people infected with severe acute respiratory syndrome coronavirus 2. The dental procedure was performed with an air turbine handpiece and HVE for 10 seconds. The efficacy of surgical masks, N95 (filtering facepiece class 2) and filtering facepiece class 3 respirators, and face shields was tested via quantitative real-time polymerase chain reaction.
RESULTS
The wide surface on which the inoculum was spread caused low contamination. Over the external surfaces of masks and respirators, when a face shield was not worn, viral loads ranged from 1.2 through 1.4 log
CONCLUSIONS
All PPE combinations significantly reduced viral loads in the operator manikin's mouth to below the detection limit, but HVE did not decrease viral contamination.
PRACTICAL IMPLICATIONS
Although caution is suggested when removing and disposing of PPE to avoid self-contamination, the combination of PPE and face shields drastically decreases the risk of transmitting human coronavirus during aerosol-generating dental procedures.

Identifiants

pubmed: 34325779
pii: S0002-8177(21)00166-5
doi: 10.1016/j.adaj.2021.03.007
pmc: PMC7997726
pii:
doi:

Substances chimiques

Aerosols 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

631-640

Informations de copyright

Copyright © 2021 American Dental Association. Published by Elsevier Inc. All rights reserved.

Références

Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Influenza Other Respir Viruses. 2017 Nov;11(6):511-517
pubmed: 28799710
Clin Infect Dis. 2012 Jun;54(11):1569-77
pubmed: 22460981
J Zhejiang Univ Sci B. 2020 May;21(5):361-368
pubmed: 32425001
Infect Control Hosp Epidemiol. 2003 Feb;24(2):139-41
pubmed: 12602698
PLoS One. 2017 May 22;12(5):e0178007
pubmed: 28531183
Evid Based Dent. 2020 Jun;21(2):56-57
pubmed: 32591659
J Occup Environ Hyg. 2016;13(4):235-42
pubmed: 26558413
Quintessence Int. 2020;51(8):660-670
pubmed: 32661521
Expert Rev Mol Diagn. 2014 Apr;14(3):323-31
pubmed: 24649819
J Dent Res. 2020 Sep;99(10):1120-1121
pubmed: 32479133
J Dent Res. 2020 Jul;99(8):989
pubmed: 32271653
Int Dent J. 2001 Feb;51(1):39-44
pubmed: 11326448
Cureus. 2020 Apr 17;12(4):e7708
pubmed: 32313785
J Hosp Infect. 2006 Sep;64(1):76-81
pubmed: 16820249
J Am Dent Assoc. 2020 Sep;151(9):660-667
pubmed: 32854868
BMC Infect Dis. 2019 Jun 3;19(1):491
pubmed: 31159777
Dent Mater. 2019 Oct;35(10):1450-1463
pubmed: 31400984
J Dent Res. 2020 May;99(5):481-487
pubmed: 32162995
J Am Dent Assoc. 2004 Apr;135(4):429-37
pubmed: 15127864
Br J Oral Maxillofac Surg. 2020 Jun;58(5):500-502
pubmed: 32307130
Int J Oral Sci. 2020 Mar 3;12(1):9
pubmed: 32127517
Influenza Other Respir Viruses. 2020 Jul;14(4):365-373
pubmed: 32246890
Lancet. 2020 Apr 25;395(10233):1382-1393
pubmed: 32277878
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Biomol Detect Quantif. 2017 Apr 29;12:1-6
pubmed: 28702366
JAMA. 2019 Sep 3;322(9):824-833
pubmed: 31479137
Phys Fluids (1994). 2020 Dec 1;32(12):127105
pubmed: 33362403
Environ Int. 2020 Nov;144:106039
pubmed: 32822927
Cochrane Database Syst Rev. 2020 Oct 12;10:CD013686
pubmed: 33047816
J Dent Res. 2020 Aug;99(9):1030-1038
pubmed: 32302257
Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164
pubmed: 18068815
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Int Dent J. 2021 Feb;71(1):21-26
pubmed: 33616049
BMJ Open. 2015 Apr 22;5(4):e006577
pubmed: 25903751
Am J Respir Crit Care Med. 2013 May 1;187(9):960-6
pubmed: 23413265

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH